Dexcom (DXCM) Free Cash Flow (2010 - 2026)
Dexcom (DXCM) posted quarterly Free Cash Flow of $184.5 million for Q2 2026, down 11.68% year-over-year from $208.9 million in Q2 2025, and down 58.91% quarter-over-quarter from $449.0 million in Q1 2026.
Dexcom (DXCM) Free Cash Flow (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Free Cash Flow for 17 consecutive years, with $184.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Free Cash Flow fell 11.68% year-over-year to $184.5 million; the TTM figure through Jun 2026 stood at $1.4 billion (up 146.15% YoY), while the FY2025 annual figure was $1.1 billion, up 70.79% from the prior year.
- Free Cash Flow fell to $184.5 million in Q2 2026 per DXCM's latest filing, from $449.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $579.4 million in Q3 2025 and bottomed at -$30.6 million in Q1 2022.
- Historically, Free Cash Flow has averaged $175.4 million across 5 years, with a median of $164.5 million in 2024.
- Annual changes were most pronounced in 2024 — Free Cash Flow tumbled 59.64% — and 2025, when it jumped 556.17%.
- Dexcom's Free Cash Flow stood at $69.0 million in 2022, then rose by 17.54% to $81.1 million in 2023, then jumped by 118.0% to $176.8 million in 2024, then climbed by 8.65% to $192.1 million in 2025, then fell by 3.96% to $184.5 million in 2026.
- Business Quant data shows DXCM's Free Cash Flow at $184.5 million in Q2 2026, $449.0 million in Q1 2026, and $192.1 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 393.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 184.50 Mn |
| Jun 30, 2026 | 184.50 Mn |
| Mar 31, 2026 | 449.00 Mn |
| Mar 31, 2026 | 449.00 Mn |
| Dec 31, 2025 | 192.10 Mn |
| Dec 31, 2025 | 192.10 Mn |
| Sep 30, 2025 | 579.40 Mn |
| Sep 30, 2025 | 579.40 Mn |
| Jun 30, 2025 | 208.90 Mn |
| Jun 30, 2025 | 208.90 Mn |
| Mar 31, 2025 | 96.80 Mn |
| Mar 31, 2025 | 96.80 Mn |
| Dec 31, 2024 | 176.80 Mn |
| Dec 31, 2024 | 176.80 Mn |
| Sep 30, 2024 | 88.30 Mn |
| Sep 30, 2024 | 88.30 Mn |
| Jun 30, 2024 | 213.30 Mn |
| Jun 30, 2024 | 213.30 Mn |
| Mar 31, 2024 | 152.30 Mn |
| Mar 31, 2024 | 152.30 Mn |